Pfizer on Tuesday said results of Phase 2 clinical trials of its experimental Lyme disease vaccine delivered “positive” results, including among pediatric trial participants.
Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a move toward potentially allowing shots for millions of youths by summer.
A city in Washington state is considering adopting a bold measure to combat the rampant homelessness that has endangered residents and plagued quality of life in the community.
The U.S. Food and Drug Administration (FDA) on Monday approved the use of the antiviral therapy, remdesivir, to treat COVID-19 in infants four weeks and older.
The Labor Department’s March inflation numbers released this month skyrocketed past February’s, hitting a 12-month increase of 8.5 percent and the steepest annual increase since 1981.
Infections have been reportedly found in half of Beijing residents, China’s capital city, a possible signal to accelerate its zero-COVID containment pace and lockdown like Shanghai. Local residents are scrambling to hoard food and supplies in fear of starving during the impending lockdown.
The U.S. trucking industry has suffered a dramatic downturn in recent months and financial analysts are worried the bad news is a presage of widespread economic trouble.
The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,237,647 reports of adverse events following COVID vaccines were submitted between Dec. 14, 2020, and April 15, 2022, to the Vaccine Adverse Event Reporting System (VAERS). VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.
